The page is the record's research on the issuer — no analyst, no rating, no view. # Entera Bio Ltd. (NASDAQ: ENTX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Entera Bio Ltd., listed on NASDAQ under ticker ENTX, with ISIN USM405271091. The LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-L3 exists. The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is Israel. The issuer is listed and not halted. ## The disclosure read The record holds 71 filings in the twelve months from 2025-11-08 to 2026-11-08, across 33 filing days. The median gap between filing days is 6.5 days. The latest filing is dated 2026-11-06, two days before the record date, and is of type results. The exchange median gap is 6.0 days across 4359 issuers, with a median of 52 filings and a median latency of 5.0 days. The sector median gap is 5.5 days across 176 issuers, with a median of 65.5 filings and a median latency of 4.0 days. The filings by type are: directors_dealings 29, regulatory_filing 14, results 10, agm_egm 5, corporate_news 5, director_change 4, prospectus 4. ## Auditor The auditor of record is Kesselman & Kesselman, located in Tel-Aviv, Israel. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is clear: listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001638097.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ENTX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1638097/000117891326001797/zk2634461.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ENTX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ENTX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp